Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Uni-science Biotechnology is a specialized medical technology company based in Wuhan, China, that focuses on the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and point-of-care testing (POCT) solutions. As a subsidiary of Wuhan Elabscience Biotechnology, the company leverages three primary technology platforms: colloidal gold immunochromatography, fluorescence immunochromatography, and pathological diagnosis antibodies. Uni-science offers a diverse product portfolio containing over 80 POCT tests covering cardiovascular health, infectious diseases, and metabolic disorders, alongside more than 200 pathological marker antibodies. Recognized as an 'Optics Valley gazelle' enterprise, the company maintains a strong global presence with products exported to over 50 countries and various certifications including ISO 13485 and CE marks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uni-science Biotechnology.